References
- Litjens RP, Brunt TM. How toxic is ibogaine? Clin Toxicol (Phila). 2016;25:1–6.
- Alper KR, Stajić M, Gill JR. Fatalities temporally associated with the ingestion of ibogaine. J Forensic Sci. 2012;57:398–412.
- Mash DC, Kovera CA, Pablo J. Ibogaine in the treatment of heroin withdrawal. Alkaloids Chem Biol. 2001;56:155–171.
- Glick SD, Maisonneuve IM, Kitchen BA, et al. Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. Eur J Pharmacol. 2002;438:99–105.
- Molinari HH, Maisonneuve IM, Glick SD. Ibogaine neurotoxicity: a re-evaluation. Brain Res. 1996;737:255–262.
- Scallet AC, Ye X, Rountree R, et al. Ibogaine produces neurodegeneration in rat, but not mouse, cerebellum. Neurohistological biomarkersof Purkinje cell loss. Ann N Y Acad Sci. 1996;801:217–226.